Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Kidle
AddedMar 31, 2024
UpdatedMay 31, 2026
Dan Kidle

Dan Kidle

Board Member, Jumpcode Genomics

CrunchbaseLinkedIn

Dan Kidle's Career

Jumpcode Genomics
Jumpcode Genomics

San Diego, CA, US

Board Member· Board
BrightSpec
BrightSpec

Charlottesville, VA, US

Board Member· Board
Akadeum Life Sciences
Akadeum Life Sciences

Ann Arbor, MI, US

Board Member· Board
Strata Oncology
Strata Oncology

Ann Arbor, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Kidle's Career

Jumpcode Genomics
Jumpcode Genomics
Series B$23.5M262015San Diego, CA, US
Board Member· Board

Leadership at Jumpcode Genomics

Keith BrownKeith BrownFounder
Kirk MalloyKirk MalloyBoard Member
Mike SalterMike SalterCEO

Similar to Jumpcode Genomics

Singular GenomicsSingular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134
BioSkryb GenomicsBioSkryb GenomicsDurham, NC, USGenomic Toolsest. 2018BioSkryb GenomicsDurham, NC, US · est. 2018

BioSkryb Genomics: Transforming single cell discovery with advanced genomic tools for disease management.

Series A · $31.5M83
MicroPure GenomicsMicroPure GenomicsAurora, CO, USGenomic Sample Prepest. 2021MicroPure GenomicsAurora, CO, US · est. 2021

MicroPure: Innovating rapid, cost-effective genomic sample preparation for advanced research.

Angel · $275k2
SequegenicsSequegenicsAtlanta, GA, USNGS Servicesest. 2016SequegenicsAtlanta, GA, US · est. 2016

Sequegenics: A cloud platform offering automated long-read NGS services for complex variant detection.

Angel · $396k6
BrightSpec
BrightSpec

Charlottesville, VA, US

Board Member· Board
Akadeum Life Sciences
Akadeum Life Sciences
Series B$21.5M352014Ann Arbor, MI, US
Board Member· Board

Leadership at Akadeum Life Sciences

Brandon McNaughtonBrandon McNaughtonFounder & CEO
William (Bill) HyunWilliam (Bill) HyunBoard Member
Strata Oncology
Strata Oncology
Series C$128M902016Ann Arbor, MI, US
Board Member· Board

Leadership at Strata Oncology

Dan RhodesDan RhodesCo-Founder
Jan GarfinkleJan GarfinkleBoard Member
Keith FlahertyKeith FlahertyCo-Founder
Scott TomlinsScott TomlinsCo-Founder
Nicole J WalkerNicole J WalkerBoard Member

Similar to Strata Oncology

OncoPrecisionOncoPrecisionNew York City, NY, USCancer Treatmentest. 2020OncoPrecisionNew York City, NY, US · est. 2020

Developing advanced tech for personalized cancer treatment and aiding in transformative therapy creation.

Seed · $4.2M37
GenomOncologyGenomOncologyCleveland, OH, USHealthcare, Softwareest. 2012GenomOncologyCleveland, OH, US · est. 2012

GenomOncology: Transforming data into actionable insights for improved cancer care.

Pre-Seed · $2.9M62
Onc.AIOnc.AISan Carlos, CA, USOncology Softwareest. 2020Onc.AISan Carlos, CA, US · est. 2020

Creating precision oncology software for clinical use, with a focus on physician-centered products.

Series A · $31M30
Certis Oncology SolutionsCertis Oncology SolutionsSan Diego, CA, USOncology Solutionsest. 2016Certis Oncology SolutionsSan Diego, CA, US · est. 2016

Certis Oncology Solutions: Precision-care provider for individualized patient care since 2016.

Series C · $10M74

Dan Kidle's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Dan Kidle

Grace ColónGrace ColónBoard Member · CareDxDan LynchDan LynchBoard Member · 2seventy bioMichael GreeleyMichael GreeleyCo-Founder · Flare Capital PartnersScott J. DyllaScott J. DyllaBoard Member · Chimera BioengineeringKen CarterKen CarterBoard Member · BioHealth InnovationEd KaniaEd KaniaBoard Member · Flagship Pioneering